Before the twentieth century, battlefield medicine relied on rudimentary methods to address preventable deaths. In the U.S. Civil War, diseases like typhoid and dysentery claimed two-thirds of the 620,000 military fatalities, surpassing combat-related injuries. By World War I, illness became the primary cause of death, with 63,000 troops lost to infection compared to 51,000 from combat. Medical advancements such as vaccines and sterile techniques reduced this gap by 1940, but uncontrolled hemorrhage remained a critical threat, with soldiers often dying within minutes of injury.
Whole blood, though vital, posed logistical challenges. Its limited shelf life and the need for blood-type matching made stockpiling impractical. Refrigerated transport improved mobility, but frontline conditions often lacked refrigeration. Back in the early 20th century, battlefield transfusions typically required a live donor, a method insufficient for large-scale conflicts.
Dr. Charles Drew, a surgeon at Columbia University, redefined blood preservation through his 1940 thesis, “Banked Blood: A Study on Blood Preservation.” He championed plasma separation, a process that eliminated blood-type constraints and enabled shelf-stable storage via lyophilization. This innovation allowed plasma to be transported without refrigeration, revolutionizing logistics. Drew’s centralized system, implemented through the Red Cross, standardized collection, testing, and distribution, shipping over 5,500 vials to Britain during the Blitz. This marked the birth of the modern blood bank.
As the U.S. entered World War II, Drew’s framework became the backbone of the military blood supply. The Red Cross expanded to 35 collection centers, using refrigerated “bloodmobiles” to reach donors. By 1944, the system reduced battlefield mortality rates significantly, demonstrating the power of organized supply chains. Though whole blood later re-emerged for severe cases, Drew’s plasma network remained foundational.
Today, the blood banking model faces renewed relevance. Modern conflicts, such as those in the Pacific or Ukraine, demand rapid, forward-deployed solutions. Freeze-dried plasma, developed post-2010, offers a shelf-stable alternative for emergencies. Ukraine’s experience highlights the urgency: damaged supply lines and antibiotic-resistant infections have forced medical units to adapt, mirroring Drew’s era. The same logistical principles he pioneered—standardization, scalability, and forward positioning—are critical to addressing these challenges.